Nutanix Study Finds Adoption of GenAI and Containers in the Healthcare Sector Has Accelerated, But IT Infrastructure Modernization to Support it Lags Behind
Nutanix (NASDAQ: NTNX) has released its seventh annual Healthcare Enterprise Cloud Index survey, revealing significant trends in healthcare technology adoption. The study found that 99% of healthcare organizations are currently using GenAI applications, leading all other industries in adoption rate.
However, the research highlighted critical challenges, with 96% of respondents indicating their current data security and governance measures are insufficient for full GenAI implementation at scale. The top challenges identified include integration with existing IT infrastructure (79%), healthcare data silos (65%), and development challenges with cloud native applications and containers (59%).
The study also revealed that 99% of healthcare organizations are in the process of containerizing applications, with 92% reporting benefits from adopting cloud native applications. Despite high adoption rates of GenAI, organizations face significant challenges in scaling these workloads from development to production, primarily due to infrastructure integration issues.
[ "99% of healthcare organizations are already leveraging GenAI applications/workloads", "92% of healthcare respondents report benefits from adopting cloud native applications/containers", "99% of healthcare organizations are implementing application containerization", "High adoption of GenAI-based customer support and code generation solutions" ]Nutanix (NASDAQ: NTNX) ha pubblicato il suo settimo sondaggio annuale Healthcare Enterprise Cloud Index, che rivela tendenze significative nell'adozione della tecnologia sanitaria. Lo studio ha rilevato che il 99% delle organizzazioni sanitarie utilizza attualmente applicazioni GenAI, posizionandosi al vertice tra tutti i settori per tasso di adozione.
Tuttavia, la ricerca ha evidenziato sfide critiche, con il 96% degli intervistati che ritiene insufficienti le attuali misure di sicurezza e governance dei dati per un'implementazione completa di GenAI su larga scala. Le principali difficoltà segnalate includono l'integrazione con l'infrastruttura IT esistente (79%), i silos di dati sanitari (65%) e le problematiche nello sviluppo di applicazioni cloud native e container (59%).
Lo studio ha inoltre rivelato che il 99% delle organizzazioni sanitarie sta containerizzando le applicazioni, con il 92% che riporta benefici dall'adozione di applicazioni cloud native. Nonostante l'elevato tasso di adozione di GenAI, le organizzazioni affrontano sfide significative nel portare questi carichi di lavoro dallo sviluppo alla produzione, principalmente a causa di problemi di integrazione dell'infrastruttura.
Nutanix (NASDAQ: NTNX) ha publicado su séptima encuesta anual Healthcare Enterprise Cloud Index, revelando tendencias significativas en la adopción de tecnología en el sector salud. El estudio encontró que el 99% de las organizaciones sanitarias están utilizando actualmente aplicaciones GenAI, liderando todos los demás sectores en tasa de adopción.
Sin embargo, la investigación destacó desafíos críticos, con el 96% de los encuestados indicando que las medidas actuales de seguridad y gobernanza de datos son insuficientes para una implementación completa de GenAI a gran escala. Los principales retos identificados incluyen la integración con la infraestructura IT existente (79%), los silos de datos sanitarios (65%) y los desafíos en el desarrollo de aplicaciones nativas de la nube y contenedores (59%).
El estudio también reveló que el 99% de las organizaciones sanitarias están en proceso de contenerizar aplicaciones, con un 92% que reporta beneficios al adoptar aplicaciones nativas de la nube. A pesar de las altas tasas de adopción de GenAI, las organizaciones enfrentan importantes desafíos para escalar estas cargas de trabajo desde el desarrollo hasta la producción, principalmente debido a problemas de integración de infraestructura.
Nutanix (NASDAQ: NTNX)는 7번째 연례 Healthcare Enterprise Cloud Index 설문조사를 발표하며 의료 기술 도입의 중요한 추세를 밝혔습니다. 연구에 따르면 99%의 의료 기관이 현재 GenAI 애플리케이션을 사용 중이며, 이는 모든 산업 중 가장 높은 도입률입니다.
하지만 조사 결과 96%의 응답자가 현재 데이터 보안 및 거버넌스 조치가 대규모 GenAI 구현에 충분하지 않다고 답했습니다. 주요 과제로는 기존 IT 인프라와의 통합(79%), 의료 데이터 사일로(65%), 클라우드 네이티브 애플리케이션 및 컨테이너 개발 문제(59%)가 꼽혔습니다.
또한 99%의 의료 기관이 애플리케이션 컨테이너화를 진행 중이며, 92%는 클라우드 네이티브 애플리케이션 도입의 이점을 보고했습니다. 높은 GenAI 도입률에도 불구하고, 인프라 통합 문제로 인해 개발에서 운영까지 워크로드 확장에 상당한 어려움을 겪고 있습니다.
Nutanix (NASDAQ : NTNX) a publié sa septième enquête annuelle Healthcare Enterprise Cloud Index, révélant des tendances importantes dans l'adoption des technologies de santé. L'étude a montré que 99 % des organisations de santé utilisent actuellement des applications GenAI, devançant tous les autres secteurs en taux d'adoption.
Cependant, la recherche a mis en lumière des défis cruciaux, avec 96 % des répondants indiquant que leurs mesures actuelles de sécurité et de gouvernance des données sont insuffisantes pour une mise en œuvre complète de GenAI à grande échelle. Les principaux obstacles identifiés incluent l'intégration avec l'infrastructure informatique existante (79 %), les silos de données de santé (65 %) et les difficultés de développement avec les applications cloud natives et les conteneurs (59 %).
L'étude a également révélé que 99 % des organisations de santé sont en train de conteneuriser leurs applications, avec 92 % rapportant des bénéfices suite à l'adoption d'applications cloud natives. Malgré un taux d'adoption élevé de GenAI, les organisations rencontrent des défis importants pour passer ces charges de travail du développement à la production, principalement à cause des problèmes d'intégration d'infrastructure.
Nutanix (NASDAQ: NTNX) hat seine siebte jährliche Healthcare Enterprise Cloud Index-Umfrage veröffentlicht, die bedeutende Trends bei der Einführung von Gesundheitstechnologien aufzeigt. Die Studie ergab, dass 99 % der Gesundheitsorganisationen derzeit GenAI-Anwendungen nutzen und damit alle anderen Branchen bei der Akzeptanz anführen.
Die Forschung hob jedoch kritische Herausforderungen hervor, wobei 96 % der Befragten angaben, dass ihre aktuellen Maßnahmen zur Datensicherheit und Governance für eine vollständige GenAI-Implementierung im großen Maßstab unzureichend sind. Die wichtigsten Herausforderungen sind die Integration in bestehende IT-Infrastrukturen (79 %), Datensilos im Gesundheitswesen (65 %) und Entwicklungsprobleme bei Cloud-nativen Anwendungen und Containern (59 %).
Die Studie zeigte außerdem, dass 99 % der Gesundheitsorganisationen Anwendungen containerisieren, wobei 92 % von Vorteilen durch die Einführung cloud-nativer Anwendungen berichten. Trotz hoher GenAI-Akzeptanz stehen Organisationen vor erheblichen Herausforderungen bei der Skalierung dieser Workloads von der Entwicklung bis zur Produktion, hauptsächlich aufgrund von Integrationsproblemen der Infrastruktur.
- None.
- 96% of organizations report insufficient data security and governance measures for GenAI
- 99% face challenges when scaling GenAI workloads from development to production
- 79% report difficulties integrating GenAI with existing IT infrastructure
- 65% struggle with healthcare data silos
Insights
Nutanix research shows healthcare rapidly adopting GenAI despite infrastructure limitations, creating market opportunity for hybrid cloud solutions.
Nutanix's seventh annual Healthcare Enterprise Cloud Index reveals a fascinating disconnect in the healthcare technology landscape. An impressive 99% of surveyed healthcare organizations are already leveraging GenAI applications - higher than any other industry - yet 96% acknowledge their current data security and governance measures are insufficient to support GenAI at scale.
This creates a classic technology adoption gap that demands attention. Healthcare organizations are enthusiastically embracing advanced technologies like GenAI and containerization (99% are at least in the process of containerizing applications), but their underlying infrastructure modernization lags critically behind. The primary integration challenges identified are illuminating:
What makes this particularly significant is healthcare's historical conservatism toward technology adoption due to strict regulatory requirements and privacy concerns. The sector's accelerated adoption of cutting-edge technologies like GenAI for chatbots, code co-pilots, and clinical development automation signals a major shift in approach, likely driven by competitive pressures and efficiency demands.
This research effectively highlights the infrastructure modernization imperative in healthcare IT. As organizations rush to implement GenAI solutions, they must simultaneously address fundamental infrastructure challenges related to security, data governance, and hybrid cloud capabilities. The findings establish a clear market need for infrastructure solutions that can bridge traditional healthcare systems with modern application architectures while maintaining the strict security and compliance requirements unique to the industry.
Modernization of legacy IT systems remains critical to meeting data security, privacy, and scalability demands for healthcare organizations
SAN JOSE, Calif., July 01, 2025 (GLOBE NEWSWIRE) -- Nutanix (NASDAQ: NTNX), a leader in hybrid multicloud computing, announced the findings of its seventh annual global Healthcare Enterprise Cloud Index (ECI) survey and research report, which measures enterprise progress with cloud adoption in the industry. The research showed that
“In healthcare, every decision we make has a direct impact on patient outcomes - including how we evolve our technology stack,” said Jon Edwards, Director IS Infrastructure Engineering at Legacy Health. “We took a close look at how to integrate GenAI responsibly, and that meant investing in infrastructure that supports long-term innovation without compromising on data privacy or security. We’re committed to modernizing our systems to deliver better care, drive efficiency, and uphold the trust that patients place in us.”
This year’s report revealed that healthcare leaders are adopting GenAI at record rates while concerns remain. The number one issue flagged by healthcare leaders is the ability to integrate it with existing IT infrastructure (
“While healthcare has typically been slower to adopt new technologies, we’ve seen a significant uptick in the adoption of GenAI, much of this likely due to the ease of access to GenAI applications and tools,” said Scott Ragsdale, Senior Director, Sales - Healthcare & SLED at Nutanix. “Even with such large adoption rates by organizations, there continue to be concerns given the importance of protecting healthcare data. Although all organizations surveyed are using GenAI in some capacity, we’ll likely see more widespread adoption within those organizations as concerns around privacy and security are resolved.”
Healthcare survey respondents were asked about GenAI adoptions and trends, Kubernetes and containers, how they’re running business and mission critical applications today, and where they plan to run them in the future. Key findings from this year’s report include:
- GenAI solution adoption and deployment across healthcare will necessitate a more comprehensive approach to data security. Healthcare respondents indicate a significant amount of work needs to be done to improve the foundational levels of data security/governance required to support GenAI solution implementation and success. The No. 1 challenge faced by healthcare organizations when it comes to leveraging or expanding utilization of GenAI is privacy and security concerns of using large language models (LLMs) with sensitive company data. Furthermore,
96% of healthcare respondents agree that their organization could be doing more to secure their GenAI models and applications. Improving data security and governance at the scale needed to support emerging GenAI workloads will be a long-term challenge and priority for many healthcare organizations. - Prioritize infrastructure modernization to support GenAI at scale across healthcare organizations. Running modern applications at enterprise scale requires infrastructure solutions that can support the necessary requirements for complex data security, data integrity and resilience. Unfortunately,
99% of healthcare respondents admit they face challenges when scaling GenAI workloads from development to production – with the No. 1 issue being integration with existing IT infrastructure. For this reason, we believe it is imperative that healthcare IT decision-makers prioritize infrastructure investments and modernization as a key enabling component of GenAI initiatives. - GenAI solution adoption in the healthcare sector continues at a rapid pace, but there are still challenges to overcome. When it comes to GenAI adoption, healthcare metrics are excellent, with
99% of industry respondents saying their organization is leveraging GenAI applications/workloads today. Most healthcare organizations believe GenAI solutions will help improve levels of productivity, automation, and efficiency. - Meanwhile, real-world GenAI use cases across healthcare segments gravitate towards GenAI-based customer support and experience solutions (e.g., chatbots), and code generation and code co-pilots. However, healthcare organizations also note a range of challenges and potential hindrances regarding GenAI solution development and deployment, including patient data security and privacy, scalability, and complexity.
- Application containerization and Kubernetes® deployments are expanding across the healthcare industry. Container-based infrastructure and application development has the potential to allow organizations to deliver seamless, secure access to patient and business data across hybrid and multicloud environments. Application containerization is pervasive across industry sectors and is set to expand in adoption across healthcare as well, with
99% of industry respondents saying their organization is at least in the process of containerizing applications.This trend may be driven by the fact that92% of healthcare respondents agree their organization benefits from adopting cloud native applications/containers. These findings suggest that the majority of IT decision-makers in healthcare will be considering how containerization fits into expansion strategies for new and existing workloads.
For the seventh consecutive year, Nutanix commissioned a global research study to learn about the state of global enterprise cloud deployments, application containerization trends, and GenAI application adoption. In the Fall of 2024, U.K. researcher Vanson Bourne surveyed 1,500 IT and DevOps/Platform Engineering decision-makers around the world. The respondent base spanned multiple industries, business sizes, and geographies, including North and South America; Europe, the Middle East and Africa (EMEA); and Asia-Pacific-Japan (APJ) region.
To learn more about the report and findings, please download the full Healthcare Nutanix Enterprise Cloud Index, here and read the blog here.
About Nutanix
Nutanix is a global leader in cloud software, offering organizations a single platform for running applications and managing data, anywhere. With Nutanix, companies can reduce complexity and simplify operations, freeing them to focus on their business outcomes. Building on its legacy as the pioneer of hyperconverged infrastructure, Nutanix is trusted by companies worldwide to power hybrid multicloud environments consistently, simply, and cost-effectively. Learn more at www.nutanix.com or follow us on social media @nutanix.
© 2025 Nutanix, Inc. All rights reserved. Nutanix, the Nutanix logo, and all Nutanix product and service names mentioned herein are registered trademarks or unregistered trademarks of Nutanix, Inc. (“Nutanix”) in the United States and other countries. Other brand names or marks mentioned herein are for identification purposes only and may be the trademarks of their respective holder(s). This press release is for informational purposes only and nothing herein constitutes a warranty or other binding commitment by Nutanix. This release may contain express and implied forward-looking statements, which are not historical facts and are instead based on Nutanix’s current expectations, estimates and beliefs. The accuracy of such statements involves risks and uncertainties and depends upon future events, including those that may be beyond Nutanix’s control, and actual results may differ materially and adversely from those anticipated or implied by such statements. Any forward-looking statements included herein speak only as of the date hereof and, except as required by law, Nutanix assumes no obligation to update or otherwise revise any of such forward-looking statements to reflect subsequent events or circumstances.

Media Contact: Gabrielle Moynan pr@nutanix.com